CSS
CALC icon

Cubist Systematic Strategies’s CalciMedica CALC Stock Holding History

Cubist Systematic Strategies’s Portfolio CALC Stock Details CALC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-730
Closed -$34K – 3469
2021
Q3 		$34K Sell
730
-665
-48% -$37.4K ﹤0.01% 2863
2021
Q2 		$106K Sell
1,395
-2,949
-68% -$193K ﹤0.01% 2712
2021
Q1 		$338K Buy
+4,344
New +$1.3M ﹤0.01% 2185

Other funds holding CALC

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Cubist Systematic Strategies's CALC Position: Q4 2021 in Review

Cubist Systematic Strategies sold out of CalciMedica (CALC) in Q4 2021, closing a stake of 730 shares — an estimated $34K sold.

Cubist Systematic Strategies first reported a position in CALC in Q1 2021 and held it in 3 quarters. The position peaked at $338K in Q1 2021. 28 funds tracked by Wall St. Rank hold CALC as of Q4 2021.

  • Cubist Systematic Strategies reported no remaining CalciMedica position as of Q4 2021 after selling out during the quarter.
  • Cubist Systematic Strategies sold 730 CalciMedica shares in Q4 2021, an estimated $34K.
  • Cubist Systematic Strategies first reported a position in CalciMedica in Q1 2021 and held it in 3 quarters.
  • Cubist Systematic Strategies's CalciMedica position peaked at $338K in Q1 2021.
  • 28 funds tracked by Wall St. Rank held CalciMedica as of Q4 2021.

Based on Cubist Systematic Strategies's 13F filing for Q4 2021, filed 14 Feb 2022.